Abreviaturas usadas en este Trabajo: IC: intervalo de confianza; RVT: respuesta virológica
temprana; TAAA: terapia antirretroviral altamente activa; IHA: índice histiológico activo; VIH …

Chronic hepatitis C (HCV) infection is currently one of the most clinically relevant
comorbidities in the HIV population; overall, it affects one third of HIV-positive individuals [1] …

Background Hepatitis C virus (HCV) infection is highly prevalent and is associated with
substantial morbidity and mortality among persons infected with the human …

ContextTreatment of chronic hepatitis C virus (HCV) infection in human immunodeficiency
virus (HIV)–infected patients is a growing concern. Most data on the virologic efficacy and …

Background: Current therapies for chronic hepatitis C virus (HCV) in HIV co-infected patients
have a low success rate and are poorly tolerated. We have evaluated the efficacy and safety …

A study was performed in 10 European health care centers in which 914 patients coinfected
with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) who had elevated …

Since the decline in HIV-related morbidity and mortality after introduction of highly active
antiretroviral therapy (HAART) in 1996, liver disease caused by chronic infection with …

Since the last consensus conference on the management of chronic viral hepatitis, a number
of studies looking at modifications of the standard course of treatment have been published …

Due to shared risk factors for transmission, coinfection with human immunodeficiency virus
(HIV) and hepatitis C virus (HCV) is a very common event. The prevalence of HCV infection …

Background The state of permanent immune activation provided by chronic HCV infection
might act deleteriously in HIV-positive individuals, favouring HIV transcription within infected …